Showing results (171-180 of 187) with videos related to

Sort By:
Pageof 19
Plos One|September 22, 2020
Circulating levels of microRNA193a-5p predict outcome in early stage hepatocellular carcinomaSven H Loosen, Theresa H Wirtz, Sanchari Roy, et al.
Journal of Hepatology|December 4, 2020
CD40-mediated immune cell activation enhances response to anti-PD-1 in murine intrahepatic cholangiocarcinomaLaurence P Diggs, Benjamin Ruf, Chi Ma, et al.
JHEP Reports : Innovation in Hepatology|April 29, 2024
Soluble urokinase plasminogen activator receptor levels predict survival in patients with portal hypertension undergoing TIPSSven H Loosen, Fabian Benz, Raphael Mohr, et al.
Cancer Cell|December 27, 2016
RIPK1 Suppresses a TRAF2-Dependent Pathway to Liver CancerAnne T Schneider, Jérémie Gautheron, Maria Feoktistova, et al.
JHEP Reports : Innovation in Hepatology|March 7, 2020
Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancerSven H Loosen, Annemarie Breuer, Frank Tacke, et al.
Hepatology (Baltimore, Md.)|September 5, 2022
Interleukin-18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosisJana Knorr, Benedikt Kaufmann, Maria Eugenia Inzaugarat, et al.
The Journal of Clinical Endocrinology and Metabolism|April 18, 2024
Obesity, Inflammation, and Clinical Outcomes in COVID-19: A Multicenter Prospective Cohort StudyChristina G Hutten, Kishan Padalia, Alexi Vasbinder, et al.
Journal of the American Heart Association|December 10, 2021
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19Michael Pan, Alexi Vasbinder, Elizabeth Anderson, et al.
Journal of the American Society of Nephrology : JASN|September 23, 2020
Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKITariq U Azam, Husam R Shadid, Pennelope Blakely, et al.
Pageof 19